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Abstract Polyphenols are found in plant-based foods and beverages, notably apples,
berries, citrus fruit, plums, broccoli, cocoa, tea and coffee and many others.
There is substantial epidemiological evidence that a diet high in polyphenol-rich
fruit, vegetables, cocoa and beverages protects against developing cardiovascular
disease and type 2 diabetes. The absorption and metabolism of these compounds
have been well described and, for many, the gut microbiota play a critical role in
absorption; taking into consideration the parent compound and the metabolites
from colon bacteria catabolism, more than 80% of a dose can be absorbed and
ultimately excreted in the urine. Common polyphenols in the diet are flavanols
(cocoa, tea, apples, broad beans), flavanones (hesperidin in citrus fruit),
hydroxycinnamates (coffee, many fruits), flavonols (quercetin in onions, apples
and tea) and anthocyanins (berries). Many intervention studies, mechanistic
in vitro data and epidemiological studies support a role for polyphenols against
the development of chronic diseases. For example, flavanols decrease endothelial
dysfunction, lower blood pressure and cholesterol, and modulate energy
metabolism. Coffee and tea both reduce the risk of developing type 2 diabetes,
through action of their constituent polyphenols. Despite extensive research, the
exact mechanisms of action of polyphenols in the human body have not been
decisively proven, but there is strong evidence that some targets such as nitric
oxide metabolism, carbohydrate digestion and oxidative enzymes are important
for health benefits. Consumption of polyphenols as healthy dietary components is
consistent with the advice to eat five or more portions of fruit and vegetables per
day, but it is currently difficult to recommend what ‘doses’ of specific
polyphenols should be consumed to derive maximum benefit.
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Introduction
Modern nutrition is a multidisciplinary subject and
draws from epidemiology, biochemistry, chemistry,
behavioural science, biology, food science and medi-
cine. It is necessary for human beings to consume food
throughout their life, and so any biological effects will
occur every day and have the potential to accumulate
over a lifetime. Food choice, food availability, genetics,
calories consumed and energy expenditure are addi-
tional factors which combine to make the subject of
nutrition treacherous for the scientist hoping to
develop hypotheses and prove theories. Biochemistry
underlies all nutritional interactions, and understand-
ing the pathways of metabolism, enzyme action and
cellular regulation are essential for understanding how
diet interacts with the body to affect health. Without
this understanding, nutrition is a black box where
scientific progress would be impossible. Nutrients com-
prise macronutrients (carbohydrate, fat and protein),
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which are digested and stored or used in the body, the
micronutrients (vitamins and minerals), which are
stored or temporarily retained in the body and are
essential for facilitating basic biochemical processes,
and the numerous other compounds that are not stored
in the body and do not contribute directly to basic bio-
chemical processes but which fine-tune cells and pro-
tect against stress, helping to improve long-term health
in many different ways. Polyphenols belong to the
latter and are a diverse group of molecules that are
consumed in all diets (Scalbert & Williamson 2000).
They originate only from plant-based foods and have
been termed non-nutrients, plant secondary metabo-
lites, phytonutrients, ‘antioxidants’, dietary bioactives
and protective factors. Although there are a large num-
ber of chemical types, fortunately the number of
polyphenols which are important in the diet is much
smaller (Hertog et al. 1995).
What are polyphenols? Nomenclature,
classifications and occurrence in foods
‘Polyphenol’ is not a strict chemical term. Today, it is
used to refer to flavonoids, tannins and phenolic acids
and their various chemically modified or polymerised
derivatives. The main classes of polyphenols in the UK
diet are flavanols (including the catechins and tannins
from tea), flavanones (mostly hesperidin from citrus
fruit), flavonols (including quercetin from tea, apples
and onions), hydroxycinnamic acids (phenolic acids,
often called ‘chlorogenic acids’ and abundant in coffee
and many fruit and vegetables) and anthocyanins
(coloured polyphenols in fruit and vegetables). For
more detailed information on the classes and
distribution, the reader is referred to compositional
databases such as Phenol-Explorer (www.phenol-
explorer.eu; Neveu et al. 2010) and to various reviews
on intake amongst different populations (Perez-Jime-
nez et al. 2011; Vogiatzoglou et al. 2014, 2015;
Nishimuro et al. 2015; Pinto & Santos 2017). Most
of the examples here will cover catechins and their oli-
gomeric ‘tannins’, quercetin, hesperidin, anthocyanins
and phenolic acids, which comprise the majority of
the dietary polyphenols in Europe and the US
(Table 1).
Absorption, metabolism and bioavailability
Absorption and metabolism of polyphenols have been
extensively studied and the biochemical pathways
related to bioavailability are well understood for the
most common classes (Fig. 1). The subject is, how-
ever, complicated by the extensive metabolism and the
complex reactions catalysed by the gut microbiota in
the colon. Classical bioavailability studies using radio-
labelled compounds indicate that most tested poly-
phenols are well absorbed. For example, after
consumption of either 14C-labelled epicatechin by vol-
unteers or 14C-procyanidin B2 by rats, the proportion
absorbed and subsequently appearing in the urine was
over 80% (Stoupi et al. 2010; Ottaviani et al. 2016).
This value includes absorption both of the parent
molecule and of the lower molecular weight com-
pounds produced by the gut microbiota. In addition,
studies on ileostomist volunteers show that several
polyphenols, such as quercetin, are well absorbed in
the small intestine (Hollman et al. 1995) and studies
using direct intestinal perfusion of volunteers show
Table 1 Content of polyphenols in foods and beverages
Chemical class Most common examples Rich sources
Mean UK intake
(mg/day)*
Comments on possible variations from the
mean in individual diets
Flavanols Catechins, gallocatechins
(monomeric and oligomeric)
Tea (epicatechins, gallocatechins,
theaﬂavins), cocoa (epicatechin,
procyanidins), apples, broad beans
(epicatechin)
590 (600) Much higher in heavy tea drinkers
Flavanones Hesperidin Citrus fruit 25 (32) Orange juice up to 500 mg/l
Flavonols Quercetin, rutin Tea, apples, onions 61 (40)
Hydoxycinnamic
acids
Chlorogenic acids
(caffeoylquinic acids)
Coffee, chicory, artichoke, plum, pears 478 (517) Up to 2000 mg/day in heavy coffee drinkers
Anthocyanins Cyanidin Berry fruits 20 (24) A 100 g portion of blackberries contains
~170 mg anthocyanins
*Data from Yahya et al. (2016) (Leeds Wellbeing study) but intakes are dependent on individual diets and highly variable. Value in parentheses shows standard
deviation.
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that enterocytes absorb and extensively metabolise
several polyphenols (Petri et al. 2003; Actis-Goretta
et al. 2015). Nevertheless, the concentration reaching
the blood is highly dependent on the parent polyphe-
nol administered and it is likely that the concentra-
tions of gut microbiota metabolites in the plasma
generally exceed that of the parent compound (and its
conjugates; Pimpao et al. 2015). The complex path-
ways of metabolism and conjugation have been well
described in the literature, and most of the general
principles are well understood (Del Rio et al. 2013;
Fig. 1), but only limited information is available on
the complex pathways of catabolism by gut micro-
biota (Woodward et al. 2011; Romo-Vaquero et al.
2015; Williamson & Clifford 2017). In general, the
peak concentrations of polyphenols in the blood post-
prandially are usually less than 1 lM, whereas, for
gut catabolites, concentrations can well exceed this
figure and are typically >10–100-fold higher than the
parent compound (Kay et al. 2009). Most of the circu-
lating metabolites, both parent compound and gut
microbiota metabolites, with some exceptions, are in
the form of glucuronides and/or sulphates and may
also be methylated (Fumeaux et al. 2010; Del Rio
et al. 2013; Borges et al. 2016; Fig. 1). For example,
several studies on bioavailability have clarified the
pathways of absorption of epicatechin in detail. The
predominant species in the plasma are 30-methyl-epica-
techin-5-O-sulphate, epicatechin-30-O-sulphate and
epicatechin-30-O-b-D-glucuronide, with epicatechin-7-
O-b-D-glucuronide additionally present in urine, and
these have been quantified based on synthesised
authentic standards (Actis-Goretta et al. 2012; Otta-
viani et al. 2012). Other detailed structures in vivo
have also been reported for quercetin (Mullen et al.
2006), hesperidin (Leveques et al. 2012) and phenolic
acids (Fumeaux et al. 2010). The extent of absorption
is also influenced by numerous factors, such as chemi-
cal attachments on the polyphenol (Jaganath et al.
2006; Guo & Bruno 2015), solubility, processing
(Neilson & Ferruzzi 2011; Cifuentes-Gomez et al.
2015) and fat content (Cermak et al. 2003).
Biological effects
Historically, polyphenols were mostly of interest to
plant scientists as they play many roles in plants and
form part of the class of secondary metabolites or
phytochemicals. In planta, they protect against stresses
such as UV light, deter attacks from pests and provide
colour to attract certain insects. In the 1930s, one of
the flavonoids, hesperidin, was proposed to be classi-
fied as a vitamin, vitamin P, and although this did not
lead to an accepted classification, it was followed by
numerous papers in the 1950s showing protective
effects on the vascular system (e.g. Drezner et al.
1955). In the 1990s, polyphenols were classified as
general antioxidants (Serafini et al. 1994) and this was
Stomach Small 
intestine
Colon
EpicatechinEpicatechin
Chlorogenic acids
hesperidin
Quercetin-
glucoside Deglycosylation
Chlorogenic acids
hesperidin
Hesperetin
Phenolics 
Blood
Microbiota
Quercetin Epicatechin
Hesperetin
Phenolics
Conjugates
Figure 1 Highly simpliﬁed metabolic pathways involved in the absorption and metabolism of polyphenols. Phenolics = hydroxycinnamic acids. Chlorogenic
acids and hesperidin are poorly absorbed intact, and so their attached organic acids and sugars, respectively, are efﬁciently removed by the gut microbiota. Deg-
lycosylation is catalysed by brush border enzymes, especially lactase phlorizin hydrolase, and is most efﬁcient when glucose is attached. Conjugates circulating
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originally thought to be a panacea to explain their
global mechanism of action. However, the reality is
much more complex and biological effects involve
detailed biochemical interactions with pathways at the
molecular level and, in this direction, much progress
has been made in the last two decades. Although
chemically polyphenols are antioxidants, this does not
necessarily transfer to biological activity because any
actions on the body depend both on bioavailability
and cellular molecular targets. The overall effect on
reducing the risk of disease is underpinned by epi-
demiology, where polyphenol-rich foods and beverages
are protective against development of some chronic
diseases, especially type 2 diabetes and cardiovascular
diseases (Yang et al. 2014a; Jumar & Schmieder
2016; Lee et al. 2016; Martin et al. 2016; Pang et al.
2016; Santos & Lima 2016). These studies are further
supported by animal studies, in vitro cell mechanistic
studies and a growing number of human intervention
studies on both healthy and at risk volunteers, which
are outlined below for selected classes of polyphenols.
Human intervention studies on flavanols
and flavanol-rich foods such as cocoa
Many human intervention studies have been reported
on cocoa, with a focus on its constituent flavanols
( ̶ )-epicatechin and its oligomers (procyanidins). In a
review of 28 human intervention studies conducted
between 2000 and 2007 on the effect of cocoa con-
sumption (Cooper et al. 2008), the main outcomes
were improved endothelial function, decreased suscep-
tibility of low-density lipoprotein (LDL) to oxidation,
inhibition of platelet aggregation and activation, and
decreased levels of F2-isoprostanes. Further interven-
tion studies have been reported and reviewed (Ding
et al. 2006; Hooper et al. 2008; Buitrago-Lopez et al.
2011; Jimenez et al. 2012; Ellam & Williamson 2013;
Kerimi & Williamson 2015; Peluso et al. 2015;
Martin et al. 2016; Vlachojannis et al. 2016). In many
studies, regular consumption of cocoa, or a flavanol
extract of cocoa, reduced blood pressure, blood
cholesterol, F2-isoprostanes and susceptibility of LDL
to oxidation. These data indicate that the most signifi-
cant changes remain as endothelial function, blood
pressure and cholesterol levels, and, together with
additional unpublished intervention studies, have
enabled a claim on cocoa flavanols to be accepted by
the European Food Safety Authority (EFSA NDA
Panel 2014) on endothelium-dependent vasodilation.
Human intervention studies supporting the claim con-
tinue to be published (Heiss et al. 2015; Mastroiacovo
et al. 2015). At the molecular level, many of the
effects are mediated through interactions with nitric
oxide metabolism in the blood vessel endothelium
(Kerimi & Williamson 2015), improving endothelial
dysfunction, increasing vasodilation and lowering
blood pressure. All of these biomarkers indicate car-
diovascular disease risk, hence providing evidence for
the protective effect of flavanols against developing
chronic cardiovascular conditions.
Human intervention studies on flavanols
and flavanol-rich foods such as tea
Tea is a rich source of catechins and gallocatechins.
Green tea contains the ‘monomeric’ compounds as
found in the plant but black tea contains mostly oxi-
dised catechins, a chemically diverse group of poly-
merised molecules called theaflavins and thearubigins.
Cocoa, green tea and black tea all contain various
amounts of epicatechin, which is one of the most active
polyphenols in these foods. It is not surprising, there-
fore, to find that some of the benefits associated with
cocoa have also been found for tea, such as reduced
risk of cardiovascular diseases (Pang et al. 2016). A
Cochrane review summarises the effects of tea, after 3-
to 6-month intervention, as lowering blood pressure,
lowering LDL-cholesterol, not affecting high-density
lipoprotein (HDL)-cholesterol and with no side effects,
with a grading of the evidence as low/moderate quality
(Santesso & Manheimer 2014). Regular consumption
of tea is also associated with reduced risk of develop-
ing type 2 diabetes in meta-analyses (Yang et al.
2014a, 2014b; Fig. 2). Despite numerous studies, the
mechanisms of action in humans in vivo are still con-
troversial and the associated anti-diabetic activities
have been ascribed to decreased rates of digestion
and nutrient absorption (Hara & Honda 1990),
such as attenuation of post-prandial glucose spikes
(Williamson 2013), activation of AMP-activated
protein kinase leading to changes in energy metabolism
(Yang et al. 2016) and effects on gut microbiota (Yang
et al. 2016).
Human intervention studies on the flavonol,
quercetin
Quercetin is mainly found in tea, apples and onions.
All of these foods contain other biologically active
components in addition to quercetin, and so some of
the effects observed for tea described above could be
partly ascribed to quercetin, and similarly for onions
and apples. Regular consumption of the latter, for
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example, reduces the risk of type 2 diabetes according
to a recent meta-analysis (Guo et al. 2017). As querce-
tin is one of the most biologically active polyphenols
in vitro, there have been several human intervention
studies on the effects of pure quercetin. When given in
the 40-O-glucoside form, which is highly bioavailable,
platelet aggregation and thrombus formation were
reduced and coincided with the appearance of querce-
tin (metabolites) in plasma (Hubbard et al. 2004).
When given chronically over 4 weeks, quercetin (as 3-
O-glucoside, also bioavailable) improved endothelial
function and reduced inflammation (Dower et al.
2015a), but did not affect flow-mediated dilation or
insulin resistance (Dower et al. 2015b). When given as
aglycone (no sugars attached), which is much less
bioavailable than the forms present in food (Shi &
Williamson 2015), quercetin as a supplement
decreased plasma uric acid in mildly hyperuricaemic
males over a period of 4 weeks (Shi & Williamson
2016), but did not affect blood pressure in normal
weight volunteers (Conquer et al. 1998; Egert et al.
2010b), platelet aggregation or serum cholesterol and
triglyceride (Conquer et al. 1998), nor protect against
oxidative stress after exercise (Nieman et al. 2007;
McAnulty et al. 2008). When given acutely, quercetin
reduced plasma endothelin-1 (Loke et al. 2008),
reduced blood pressure in overweight volunteers but
only of a certain genotype (Egert et al. 2010a), but
did not reduce urinary F2-isoprostanes (Loke et al.
2008), nor blood pressure in normal weight volunteers
(Egert et al. 2010b). When given in the form of onion
skin extract, quercetin did not affect systemic inflam-
mation in overweight women (Kim & Yim 2016),
post-prandial blood pressure, endothelial function,
serum leptin nor adiponectin in overweight adults
(Brull et al. 2016, 2017). These various studies suggest
that quercetin exerts some effects in humans but the
exact effect is highly dependent on the individual’s
metabolic and genetic status, and on the form given.
As many of the studies gave relatively high doses, at
this stage, more research is required to define the
effect of quercetin from dietary sources.
Human intervention studies on
hydroxycinnamic acids and coffee
Many reviews and intervention studies have been
reported on coffee and its constituent hydroxycin-
namic acids (chlorogenic acids). The epidemiological
evidence for a protective effect of coffee consumption
against the risk of developing type 2 diabetes is very
strong and shows a convincing dose-dependent effect
(Fig. 2). Data from systematic reviews and meta-ana-
lyses show that the reduction in risk is ~8% for each
cup of coffee consumed per day and that this is inde-
pendent of whether the coffee is decaffeinated or not
(Bhupathiraju et al. 2013; Ding et al. 2014). Some
well-publicised studies indicated that when coffee was
boiled in the ‘Scandinavian’ way, there was an
increase in plasma cholesterol (Zock et al. 1990), but
these effects were due to cafestol and kahweol (Urgert
et al. 1996). These components are not polyphenols
and are present only in certain types of coffee (Urgert
& Katan 1997). Intervention studies on coffee are
more mixed and study designs are complicated by the
fact that it is difficult to examine the effect of coffee
consumption in regular coffee drinkers. The amount
can either be increased to try to measure an additional
effect of higher consumption, or coffee can be with-
drawn for a period before reintroduction. In studies of
the latter design, coffee over 4 weeks, after a 4-week
washout, attenuated DNA damage, reduced body-
weight and body fat (Bakuradze et al. 2011), and
exerted beneficial effects on subclinical inflammation
and HDL-cholesterol (Kempf et al. 2010). Coffee con-
sumption over 1 week has been reported to increase
(Olthof et al. 2001) or not affect (Esposito et al.
2003) plasma homocysteine. Unfavourable effects of
coffee on endothelial function (Buscemi et al. 2010)
were in contrast to favourable effects of decaffeinated
coffee (Buscemi et al. 2009). A more recent interven-
tion where healthy volunteers received coffee for
2 months had no effect on markers of oxidation of
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Figure 2 Relative risk reduction of developing type 2 diabetes with tea
and coffee consumption. Plotted values for tea are from Yang et al. (2014b)
and for coffee are from Ding et al. (2014). Reduction in risk calculated
directly from [100-relative risk (%)], and error bars indicate the upper and
lower conﬁdence intervals as reported in the cited papers. Data on coffee
are consistent with studies by Bhupathiraju et al. (2013), who also showed
that the reduction in risk was similar or even better (depending on cohort)
for consumption of decaffeinated coffee compared to regular. Data on tea
are supported by the meta-analysis reported by Yang et al. (2014a). [Colour
ﬁgure can be viewed at wileyonlinelibrary.com]
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DNA and lipids, plasma glucose and insulin, choles-
terol, triglycerides, inflammatory markers, nor on
blood pressure (Shaposhnikov et al. 2016). Neverthe-
less, a recent review on the effects of coffee from 26
intervention studies suggests that coffee consumption
increases glutathione levels and protects against DNA
damage, but with inconclusive effects on protein and
lipid damage (Martini et al. 2016). Studies showing
convincing mechanisms of action of coffee hydrox-
ycinnamic acids are also lacking, but include effects
on fat metabolism and the gut microbiota (Pan et al.
2016). The metabolism of chlorogenic acids from cof-
fee is now well understood, involving critical action of
gut microbiota, and knowledge on the plasma metabo-
lites of chlorogenic acids should facilitate more mecha-
nistic studies in the future. While the epidemiological
data for coffee reducing the risk of type 2 diabetes are
very convincing, the data are not yet backed up by
well-designed larger-scale intervention studies and
convincing mechanisms. Coffee consumption may also
reduce the risk of colon cancer (Schmit et al. 2016),
does not increase hypertension (Rhee et al. 2016) nor
cancer risk (Arab 2010) and may be protective against
cardiovascular disease (Crippa et al. 2014). Although
many of the protective effects of coffee have been
assigned to the constituent chlorogenic acids, there are
very few intervention studies on pure chlorogenic
acids in humans. A chlorogenic acid-rich green coffee
extract given for 12 weeks decreased both systolic and
diastolic blood pressure, but did not affect body mass
index nor pulse rate in patients with mild hyperten-
sion (Watanabe et al. 2006), and after consumption of
an acute high dose of chlorogenic acid, there was no
change in glucose tolerance via effects on incretin hor-
mone secretion (Olthof et al. 2011). Clearly, one of
the difficulties in making conclusions on the polyphe-
nol component of coffee is separating out the effects
of caffeine, which has substantial biological activity
both positive and negative, and in addition, the pres-
ence of hydroxycinnamic acids may protect against
some of the effects of caffeine.
Supplements or not?
Supplements have the advantage of delivering a suit-
ably active dose but also have several drawbacks.
Often polyphenols act with other nutrients and a key
example is where polyphenols already present in food
slow down the rate of carbohydrate digestion to blunt
post-prandial glucose spikes (Williamson 2013). If
taken without food, a supplement would be unable to
have any effect on this parameter and so the ideal
situation would be to consume the polyphenol with
food (i.e. in its natural state). In addition, supplements
may have modified bioavailability and can also dis-
courage the consumption of a ‘healthy’ diet in favour
of supplementing a poor diet. The use of plant food
supplements (botanical supplements) in Europe has
been reviewed (Vargas-Murga et al. 2011), and in a
survey of people from six countries (Finland, Ger-
many, Italy, Romania, Spain and the UK), almost
20% of those asked consumed plant food supple-
ments, containing a total of more than 490 different
ingredients, with the most common ones being Ginkgo
biloba, Oenothera biennis (Evening primrose) and
Cynara scolymus (Artichoke) (Garcia-Alvarez et al.
2014).
Future perspectives
Most micronutrients such as vitamins and minerals
have an officially approved daily intake recommended
value, with these varying between countries and
regions. Although initially proposed for polyphenols
(Williamson & Holst 2008), differences between
polyphenols and vitamins suggest that a somewhat dif-
ferent approach is needed. This is based on the
assumption that a sufficient dose for an effect is
needed every time of consumption and that, unlike
minerals and vitamins, the active component is not
stored or temporarily retained in the body. For exam-
ple, a food containing 10 mg of a certain mineral will
contribute 10% to a daily intake recommended value
of 100 mg, and 10 doses will therefore constitute suf-
ficient daily intake. On the other hand, for compo-
nents with a proposed beneficial effect, such as cocoa
flavanols, but not stored in the body, the magnitude
of the effect is dependent on dose. The critical ques-
tion is how much is needed for the smallest biologi-
cally significant effect, which would then be effective
and observable over a suitable period of time. This is
a truly important question in this area if we consider
a situation where the daily effect of an acute dose is
not measurable by current biomarker technology, but
the effect (not the actual compound) builds up and
becomes apparent over a period of weeks, months or
even years. Let us consider that the amount necessary
for a given effect by a hypothetical flavonoid is 10 mg
per day and that the effect is apparent after 2 months.
If we give a food containing a ‘dose’ of 5 mg, this
may not elicit this threshold effect and so the dose
could be considered as ‘wasted’, at least in terms of
affecting the desired biomarker. Therefore, one propo-
sition is that the recommended daily intake for these
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compounds cannot be achieved by administering
2 9 5 mg doses separately, only by a single 10 mg
bolus. This needs to be considered and scientifically
evaluated before any compound-specific recommenda-
tions on intake can be made.
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